nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Upper respiratory tract infection—Epirubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Methylphenidate—Asthma—Doxorubicin—sarcoma	0.000888	0.000888	CcSEcCtD
Methylphenidate—Influenza—Doxorubicin—sarcoma	0.000888	0.000888	CcSEcCtD
Methylphenidate—Hypersensitivity—Vincristine—sarcoma	0.000886	0.000886	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Epirubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Methylphenidate—Paraesthesia—Etoposide—sarcoma	0.000875	0.000875	CcSEcCtD
Methylphenidate—Weight increased—Epirubicin—sarcoma	0.000874	0.000874	CcSEcCtD
Methylphenidate—Pancreatitis—Doxorubicin—sarcoma	0.000871	0.000871	CcSEcCtD
Methylphenidate—Weight decreased—Epirubicin—sarcoma	0.000869	0.000869	CcSEcCtD
Methylphenidate—Dyspnoea—Etoposide—sarcoma	0.000868	0.000868	CcSEcCtD
Methylphenidate—Somnolence—Etoposide—sarcoma	0.000866	0.000866	CcSEcCtD
Methylphenidate—Angina pectoris—Doxorubicin—sarcoma	0.000865	0.000865	CcSEcCtD
Methylphenidate—Hypersensitivity—Mitoxantrone—sarcoma	0.000863	0.000863	CcSEcCtD
Methylphenidate—Asthenia—Vincristine—sarcoma	0.000863	0.000863	CcSEcCtD
Methylphenidate—Vomiting—Thiotepa—sarcoma	0.000862	0.000862	CcSEcCtD
Methylphenidate—Pneumonia—Epirubicin—sarcoma	0.000861	0.000861	CcSEcCtD
Methylphenidate—Infestation—Epirubicin—sarcoma	0.000856	0.000856	CcSEcCtD
Methylphenidate—Drowsiness—Epirubicin—sarcoma	0.000856	0.000856	CcSEcCtD
Methylphenidate—Infestation NOS—Epirubicin—sarcoma	0.000856	0.000856	CcSEcCtD
Methylphenidate—Vomiting—Dactinomycin—sarcoma	0.000856	0.000856	CcSEcCtD
Methylphenidate—Rash—Thiotepa—sarcoma	0.000855	0.000855	CcSEcCtD
Methylphenidate—Bronchitis—Doxorubicin—sarcoma	0.000854	0.000854	CcSEcCtD
Methylphenidate—Dermatitis—Thiotepa—sarcoma	0.000854	0.000854	CcSEcCtD
Methylphenidate—Headache—Thiotepa—sarcoma	0.00085	0.00085	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000849	0.000849	CcSEcCtD
Methylphenidate—Rash—Dactinomycin—sarcoma	0.000849	0.000849	CcSEcCtD
Methylphenidate—Decreased appetite—Etoposide—sarcoma	0.000847	0.000847	CcSEcCtD
Methylphenidate—Pancytopenia—Doxorubicin—sarcoma	0.000844	0.000844	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Etoposide—sarcoma	0.000841	0.000841	CcSEcCtD
Methylphenidate—Asthenia—Mitoxantrone—sarcoma	0.00084	0.00084	CcSEcCtD
Methylphenidate—Fatigue—Etoposide—sarcoma	0.00084	0.00084	CcSEcCtD
Methylphenidate—Constipation—Etoposide—sarcoma	0.000833	0.000833	CcSEcCtD
Methylphenidate—Pain—Etoposide—sarcoma	0.000833	0.000833	CcSEcCtD
Methylphenidate—Conjunctivitis—Epirubicin—sarcoma	0.000832	0.000832	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000826	0.000826	CcSEcCtD
Methylphenidate—Diarrhoea—Vincristine—sarcoma	0.000823	0.000823	CcSEcCtD
Methylphenidate—Sweating—Epirubicin—sarcoma	0.000821	0.000821	CcSEcCtD
Methylphenidate—Haematuria—Epirubicin—sarcoma	0.000816	0.000816	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Doxorubicin—sarcoma	0.000811	0.000811	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Epirubicin—sarcoma	0.00081	0.00081	CcSEcCtD
Methylphenidate—Weight increased—Doxorubicin—sarcoma	0.000809	0.000809	CcSEcCtD
Methylphenidate—Epistaxis—Epirubicin—sarcoma	0.000808	0.000808	CcSEcCtD
Methylphenidate—Nausea—Thiotepa—sarcoma	0.000806	0.000806	CcSEcCtD
Methylphenidate—Weight decreased—Doxorubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Methylphenidate—Sinusitis—Epirubicin—sarcoma	0.000803	0.000803	CcSEcCtD
Methylphenidate—Feeling abnormal—Etoposide—sarcoma	0.000803	0.000803	CcSEcCtD
Methylphenidate—Diarrhoea—Mitoxantrone—sarcoma	0.000801	0.000801	CcSEcCtD
Methylphenidate—Nausea—Dactinomycin—sarcoma	0.000799	0.000799	CcSEcCtD
Methylphenidate—Pneumonia—Doxorubicin—sarcoma	0.000797	0.000797	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Etoposide—sarcoma	0.000797	0.000797	CcSEcCtD
Methylphenidate—Dizziness—Vincristine—sarcoma	0.000795	0.000795	CcSEcCtD
Methylphenidate—Infestation NOS—Doxorubicin—sarcoma	0.000792	0.000792	CcSEcCtD
Methylphenidate—Infestation—Doxorubicin—sarcoma	0.000792	0.000792	CcSEcCtD
Methylphenidate—Drowsiness—Doxorubicin—sarcoma	0.000792	0.000792	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000785	0.000785	CcSEcCtD
Methylphenidate—Bradycardia—Epirubicin—sarcoma	0.000782	0.000782	CcSEcCtD
Methylphenidate—Urticaria—Etoposide—sarcoma	0.000774	0.000774	CcSEcCtD
Methylphenidate—Haemoglobin—Epirubicin—sarcoma	0.000772	0.000772	CcSEcCtD
Methylphenidate—Rhinitis—Epirubicin—sarcoma	0.000771	0.000771	CcSEcCtD
Methylphenidate—Body temperature increased—Etoposide—sarcoma	0.00077	0.00077	CcSEcCtD
Methylphenidate—Abdominal pain—Etoposide—sarcoma	0.00077	0.00077	CcSEcCtD
Methylphenidate—Conjunctivitis—Doxorubicin—sarcoma	0.00077	0.00077	CcSEcCtD
Methylphenidate—Haemorrhage—Epirubicin—sarcoma	0.000769	0.000769	CcSEcCtD
Methylphenidate—Vomiting—Vincristine—sarcoma	0.000765	0.000765	CcSEcCtD
Methylphenidate—Pharyngitis—Epirubicin—sarcoma	0.000763	0.000763	CcSEcCtD
Methylphenidate—Sweating—Doxorubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Methylphenidate—Urinary tract disorder—Epirubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Methylphenidate—Rash—Vincristine—sarcoma	0.000758	0.000758	CcSEcCtD
Methylphenidate—Dermatitis—Vincristine—sarcoma	0.000758	0.000758	CcSEcCtD
Methylphenidate—Haematuria—Doxorubicin—sarcoma	0.000755	0.000755	CcSEcCtD
Methylphenidate—Connective tissue disorder—Epirubicin—sarcoma	0.000755	0.000755	CcSEcCtD
Methylphenidate—Urethral disorder—Epirubicin—sarcoma	0.000753	0.000753	CcSEcCtD
Methylphenidate—Headache—Vincristine—sarcoma	0.000753	0.000753	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Doxorubicin—sarcoma	0.000749	0.000749	CcSEcCtD
Methylphenidate—Epistaxis—Doxorubicin—sarcoma	0.000747	0.000747	CcSEcCtD
Methylphenidate—Vomiting—Mitoxantrone—sarcoma	0.000745	0.000745	CcSEcCtD
Methylphenidate—Sinusitis—Doxorubicin—sarcoma	0.000743	0.000743	CcSEcCtD
Methylphenidate—Visual impairment—Epirubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Methylphenidate—Rash—Mitoxantrone—sarcoma	0.000738	0.000738	CcSEcCtD
Methylphenidate—Dermatitis—Mitoxantrone—sarcoma	0.000738	0.000738	CcSEcCtD
Methylphenidate—Headache—Mitoxantrone—sarcoma	0.000734	0.000734	CcSEcCtD
Methylphenidate—Erythema multiforme—Epirubicin—sarcoma	0.000727	0.000727	CcSEcCtD
Methylphenidate—Bradycardia—Doxorubicin—sarcoma	0.000724	0.000724	CcSEcCtD
Methylphenidate—Eye disorder—Epirubicin—sarcoma	0.000718	0.000718	CcSEcCtD
Methylphenidate—Hypersensitivity—Etoposide—sarcoma	0.000718	0.000718	CcSEcCtD
Methylphenidate—Haemoglobin—Doxorubicin—sarcoma	0.000715	0.000715	CcSEcCtD
Methylphenidate—Nausea—Vincristine—sarcoma	0.000714	0.000714	CcSEcCtD
Methylphenidate—Flushing—Epirubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Methylphenidate—Cardiac disorder—Epirubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Methylphenidate—Rhinitis—Doxorubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Methylphenidate—Haemorrhage—Doxorubicin—sarcoma	0.000711	0.000711	CcSEcCtD
Methylphenidate—Pharyngitis—Doxorubicin—sarcoma	0.000706	0.000706	CcSEcCtD
Methylphenidate—Urinary tract disorder—Doxorubicin—sarcoma	0.000702	0.000702	CcSEcCtD
Methylphenidate—Asthenia—Etoposide—sarcoma	0.000699	0.000699	CcSEcCtD
Methylphenidate—Connective tissue disorder—Doxorubicin—sarcoma	0.000699	0.000699	CcSEcCtD
Methylphenidate—Angiopathy—Epirubicin—sarcoma	0.000697	0.000697	CcSEcCtD
Methylphenidate—Urethral disorder—Doxorubicin—sarcoma	0.000697	0.000697	CcSEcCtD
Methylphenidate—Nausea—Mitoxantrone—sarcoma	0.000696	0.000696	CcSEcCtD
Methylphenidate—Immune system disorder—Epirubicin—sarcoma	0.000694	0.000694	CcSEcCtD
Methylphenidate—Mediastinal disorder—Epirubicin—sarcoma	0.000693	0.000693	CcSEcCtD
Methylphenidate—Chills—Epirubicin—sarcoma	0.00069	0.00069	CcSEcCtD
Methylphenidate—Pruritus—Etoposide—sarcoma	0.000689	0.000689	CcSEcCtD
Methylphenidate—Arrhythmia—Epirubicin—sarcoma	0.000687	0.000687	CcSEcCtD
Methylphenidate—Visual impairment—Doxorubicin—sarcoma	0.000685	0.000685	CcSEcCtD
Methylphenidate—Alopecia—Epirubicin—sarcoma	0.000679	0.000679	CcSEcCtD
Methylphenidate—Mental disorder—Epirubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Methylphenidate—Erythema multiforme—Doxorubicin—sarcoma	0.000672	0.000672	CcSEcCtD
Methylphenidate—Malnutrition—Epirubicin—sarcoma	0.000669	0.000669	CcSEcCtD
Methylphenidate—Erythema—Epirubicin—sarcoma	0.000669	0.000669	CcSEcCtD
Methylphenidate—Diarrhoea—Etoposide—sarcoma	0.000667	0.000667	CcSEcCtD
Methylphenidate—Eye disorder—Doxorubicin—sarcoma	0.000665	0.000665	CcSEcCtD
Methylphenidate—Flushing—Doxorubicin—sarcoma	0.00066	0.00066	CcSEcCtD
Methylphenidate—Cardiac disorder—Doxorubicin—sarcoma	0.00066	0.00066	CcSEcCtD
Methylphenidate—Tension—Epirubicin—sarcoma	0.000657	0.000657	CcSEcCtD
Methylphenidate—Nervousness—Epirubicin—sarcoma	0.00065	0.00065	CcSEcCtD
Methylphenidate—Back pain—Epirubicin—sarcoma	0.000647	0.000647	CcSEcCtD
Methylphenidate—Angiopathy—Doxorubicin—sarcoma	0.000645	0.000645	CcSEcCtD
Methylphenidate—Dizziness—Etoposide—sarcoma	0.000644	0.000644	CcSEcCtD
Methylphenidate—Muscle spasms—Epirubicin—sarcoma	0.000643	0.000643	CcSEcCtD
Methylphenidate—Immune system disorder—Doxorubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Methylphenidate—Mediastinal disorder—Doxorubicin—sarcoma	0.000641	0.000641	CcSEcCtD
Methylphenidate—Chills—Doxorubicin—sarcoma	0.000638	0.000638	CcSEcCtD
Methylphenidate—Arrhythmia—Doxorubicin—sarcoma	0.000635	0.000635	CcSEcCtD
Methylphenidate—Vision blurred—Epirubicin—sarcoma	0.000631	0.000631	CcSEcCtD
Methylphenidate—Alopecia—Doxorubicin—sarcoma	0.000628	0.000628	CcSEcCtD
Methylphenidate—Mental disorder—Doxorubicin—sarcoma	0.000623	0.000623	CcSEcCtD
Methylphenidate—Ill-defined disorder—Epirubicin—sarcoma	0.000621	0.000621	CcSEcCtD
Methylphenidate—Vomiting—Etoposide—sarcoma	0.000619	0.000619	CcSEcCtD
Methylphenidate—Malnutrition—Doxorubicin—sarcoma	0.000619	0.000619	CcSEcCtD
Methylphenidate—Erythema—Doxorubicin—sarcoma	0.000619	0.000619	CcSEcCtD
Methylphenidate—Anaemia—Epirubicin—sarcoma	0.000618	0.000618	CcSEcCtD
Methylphenidate—Agitation—Epirubicin—sarcoma	0.000615	0.000615	CcSEcCtD
Methylphenidate—Rash—Etoposide—sarcoma	0.000614	0.000614	CcSEcCtD
Methylphenidate—Dermatitis—Etoposide—sarcoma	0.000614	0.000614	CcSEcCtD
Methylphenidate—Headache—Etoposide—sarcoma	0.00061	0.00061	CcSEcCtD
Methylphenidate—Tension—Doxorubicin—sarcoma	0.000608	0.000608	CcSEcCtD
Methylphenidate—Malaise—Epirubicin—sarcoma	0.000603	0.000603	CcSEcCtD
Methylphenidate—Nervousness—Doxorubicin—sarcoma	0.000601	0.000601	CcSEcCtD
Methylphenidate—Vertigo—Epirubicin—sarcoma	0.000601	0.000601	CcSEcCtD
Methylphenidate—Syncope—Epirubicin—sarcoma	0.0006	0.0006	CcSEcCtD
Methylphenidate—Leukopenia—Epirubicin—sarcoma	0.000599	0.000599	CcSEcCtD
Methylphenidate—Back pain—Doxorubicin—sarcoma	0.000599	0.000599	CcSEcCtD
Methylphenidate—Muscle spasms—Doxorubicin—sarcoma	0.000595	0.000595	CcSEcCtD
Methylphenidate—Palpitations—Epirubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Methylphenidate—Loss of consciousness—Epirubicin—sarcoma	0.000588	0.000588	CcSEcCtD
Methylphenidate—Cough—Epirubicin—sarcoma	0.000584	0.000584	CcSEcCtD
Methylphenidate—Vision blurred—Doxorubicin—sarcoma	0.000583	0.000583	CcSEcCtD
Methylphenidate—Convulsion—Epirubicin—sarcoma	0.00058	0.00058	CcSEcCtD
Methylphenidate—Nausea—Etoposide—sarcoma	0.000579	0.000579	CcSEcCtD
Methylphenidate—Hypertension—Epirubicin—sarcoma	0.000578	0.000578	CcSEcCtD
Methylphenidate—Ill-defined disorder—Doxorubicin—sarcoma	0.000574	0.000574	CcSEcCtD
Methylphenidate—Anaemia—Doxorubicin—sarcoma	0.000572	0.000572	CcSEcCtD
Methylphenidate—Myalgia—Epirubicin—sarcoma	0.00057	0.00057	CcSEcCtD
Methylphenidate—Arthralgia—Epirubicin—sarcoma	0.00057	0.00057	CcSEcCtD
Methylphenidate—Chest pain—Epirubicin—sarcoma	0.00057	0.00057	CcSEcCtD
Methylphenidate—Agitation—Doxorubicin—sarcoma	0.000569	0.000569	CcSEcCtD
Methylphenidate—Anxiety—Epirubicin—sarcoma	0.000568	0.000568	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000566	0.000566	CcSEcCtD
Methylphenidate—Discomfort—Epirubicin—sarcoma	0.000563	0.000563	CcSEcCtD
Methylphenidate—Malaise—Doxorubicin—sarcoma	0.000558	0.000558	CcSEcCtD
Methylphenidate—Dry mouth—Epirubicin—sarcoma	0.000557	0.000557	CcSEcCtD
Methylphenidate—Vertigo—Doxorubicin—sarcoma	0.000556	0.000556	CcSEcCtD
Methylphenidate—Syncope—Doxorubicin—sarcoma	0.000555	0.000555	CcSEcCtD
Methylphenidate—Leukopenia—Doxorubicin—sarcoma	0.000554	0.000554	CcSEcCtD
Methylphenidate—Confusional state—Epirubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Methylphenidate—Palpitations—Doxorubicin—sarcoma	0.000547	0.000547	CcSEcCtD
Methylphenidate—Anaphylactic shock—Epirubicin—sarcoma	0.000546	0.000546	CcSEcCtD
Methylphenidate—Oedema—Epirubicin—sarcoma	0.000546	0.000546	CcSEcCtD
Methylphenidate—Loss of consciousness—Doxorubicin—sarcoma	0.000544	0.000544	CcSEcCtD
Methylphenidate—Infection—Epirubicin—sarcoma	0.000542	0.000542	CcSEcCtD
Methylphenidate—Cough—Doxorubicin—sarcoma	0.00054	0.00054	CcSEcCtD
Methylphenidate—Shock—Epirubicin—sarcoma	0.000537	0.000537	CcSEcCtD
Methylphenidate—Convulsion—Doxorubicin—sarcoma	0.000536	0.000536	CcSEcCtD
Methylphenidate—Nervous system disorder—Epirubicin—sarcoma	0.000536	0.000536	CcSEcCtD
Methylphenidate—Thrombocytopenia—Epirubicin—sarcoma	0.000535	0.000535	CcSEcCtD
Methylphenidate—Hypertension—Doxorubicin—sarcoma	0.000534	0.000534	CcSEcCtD
Methylphenidate—Tachycardia—Epirubicin—sarcoma	0.000533	0.000533	CcSEcCtD
Methylphenidate—Skin disorder—Epirubicin—sarcoma	0.00053	0.00053	CcSEcCtD
Methylphenidate—Hyperhidrosis—Epirubicin—sarcoma	0.000528	0.000528	CcSEcCtD
Methylphenidate—Chest pain—Doxorubicin—sarcoma	0.000527	0.000527	CcSEcCtD
Methylphenidate—Myalgia—Doxorubicin—sarcoma	0.000527	0.000527	CcSEcCtD
Methylphenidate—Arthralgia—Doxorubicin—sarcoma	0.000527	0.000527	CcSEcCtD
Methylphenidate—Anxiety—Doxorubicin—sarcoma	0.000525	0.000525	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000523	0.000523	CcSEcCtD
Methylphenidate—Discomfort—Doxorubicin—sarcoma	0.000521	0.000521	CcSEcCtD
Methylphenidate—Anorexia—Epirubicin—sarcoma	0.000521	0.000521	CcSEcCtD
Methylphenidate—Dry mouth—Doxorubicin—sarcoma	0.000515	0.000515	CcSEcCtD
Methylphenidate—Confusional state—Doxorubicin—sarcoma	0.000509	0.000509	CcSEcCtD
Methylphenidate—Oedema—Doxorubicin—sarcoma	0.000505	0.000505	CcSEcCtD
Methylphenidate—Anaphylactic shock—Doxorubicin—sarcoma	0.000505	0.000505	CcSEcCtD
Methylphenidate—Infection—Doxorubicin—sarcoma	0.000502	0.000502	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000497	0.000497	CcSEcCtD
Methylphenidate—Shock—Doxorubicin—sarcoma	0.000497	0.000497	CcSEcCtD
Methylphenidate—Nervous system disorder—Doxorubicin—sarcoma	0.000495	0.000495	CcSEcCtD
Methylphenidate—Thrombocytopenia—Doxorubicin—sarcoma	0.000495	0.000495	CcSEcCtD
Methylphenidate—Insomnia—Epirubicin—sarcoma	0.000494	0.000494	CcSEcCtD
Methylphenidate—Tachycardia—Doxorubicin—sarcoma	0.000493	0.000493	CcSEcCtD
Methylphenidate—Skin disorder—Doxorubicin—sarcoma	0.000491	0.000491	CcSEcCtD
Methylphenidate—Paraesthesia—Epirubicin—sarcoma	0.00049	0.00049	CcSEcCtD
Methylphenidate—Hyperhidrosis—Doxorubicin—sarcoma	0.000488	0.000488	CcSEcCtD
Methylphenidate—Dyspnoea—Epirubicin—sarcoma	0.000487	0.000487	CcSEcCtD
Methylphenidate—Somnolence—Epirubicin—sarcoma	0.000485	0.000485	CcSEcCtD
Methylphenidate—Anorexia—Doxorubicin—sarcoma	0.000482	0.000482	CcSEcCtD
Methylphenidate—Dyspepsia—Epirubicin—sarcoma	0.000481	0.000481	CcSEcCtD
Methylphenidate—Decreased appetite—Epirubicin—sarcoma	0.000475	0.000475	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Epirubicin—sarcoma	0.000471	0.000471	CcSEcCtD
Methylphenidate—Fatigue—Epirubicin—sarcoma	0.000471	0.000471	CcSEcCtD
Methylphenidate—Constipation—Epirubicin—sarcoma	0.000467	0.000467	CcSEcCtD
Methylphenidate—Pain—Epirubicin—sarcoma	0.000467	0.000467	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00046	0.00046	CcSEcCtD
Methylphenidate—Insomnia—Doxorubicin—sarcoma	0.000457	0.000457	CcSEcCtD
Methylphenidate—Paraesthesia—Doxorubicin—sarcoma	0.000454	0.000454	CcSEcCtD
Methylphenidate—Dyspnoea—Doxorubicin—sarcoma	0.00045	0.00045	CcSEcCtD
Methylphenidate—Feeling abnormal—Epirubicin—sarcoma	0.00045	0.00045	CcSEcCtD
Methylphenidate—Somnolence—Doxorubicin—sarcoma	0.000449	0.000449	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Epirubicin—sarcoma	0.000447	0.000447	CcSEcCtD
Methylphenidate—Dyspepsia—Doxorubicin—sarcoma	0.000445	0.000445	CcSEcCtD
Methylphenidate—Decreased appetite—Doxorubicin—sarcoma	0.000439	0.000439	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000436	0.000436	CcSEcCtD
Methylphenidate—Fatigue—Doxorubicin—sarcoma	0.000436	0.000436	CcSEcCtD
Methylphenidate—Urticaria—Epirubicin—sarcoma	0.000434	0.000434	CcSEcCtD
Methylphenidate—Pain—Doxorubicin—sarcoma	0.000432	0.000432	CcSEcCtD
Methylphenidate—Constipation—Doxorubicin—sarcoma	0.000432	0.000432	CcSEcCtD
Methylphenidate—Abdominal pain—Epirubicin—sarcoma	0.000432	0.000432	CcSEcCtD
Methylphenidate—Body temperature increased—Epirubicin—sarcoma	0.000432	0.000432	CcSEcCtD
Methylphenidate—Feeling abnormal—Doxorubicin—sarcoma	0.000416	0.000416	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000413	0.000413	CcSEcCtD
Methylphenidate—Hypersensitivity—Epirubicin—sarcoma	0.000402	0.000402	CcSEcCtD
Methylphenidate—Urticaria—Doxorubicin—sarcoma	0.000401	0.000401	CcSEcCtD
Methylphenidate—Body temperature increased—Doxorubicin—sarcoma	0.000399	0.000399	CcSEcCtD
Methylphenidate—Abdominal pain—Doxorubicin—sarcoma	0.000399	0.000399	CcSEcCtD
Methylphenidate—Asthenia—Epirubicin—sarcoma	0.000392	0.000392	CcSEcCtD
Methylphenidate—Pruritus—Epirubicin—sarcoma	0.000386	0.000386	CcSEcCtD
Methylphenidate—Diarrhoea—Epirubicin—sarcoma	0.000374	0.000374	CcSEcCtD
Methylphenidate—Hypersensitivity—Doxorubicin—sarcoma	0.000372	0.000372	CcSEcCtD
Methylphenidate—Asthenia—Doxorubicin—sarcoma	0.000363	0.000363	CcSEcCtD
Methylphenidate—Dizziness—Epirubicin—sarcoma	0.000361	0.000361	CcSEcCtD
Methylphenidate—Pruritus—Doxorubicin—sarcoma	0.000357	0.000357	CcSEcCtD
Methylphenidate—Vomiting—Epirubicin—sarcoma	0.000347	0.000347	CcSEcCtD
Methylphenidate—Diarrhoea—Doxorubicin—sarcoma	0.000346	0.000346	CcSEcCtD
Methylphenidate—Rash—Epirubicin—sarcoma	0.000344	0.000344	CcSEcCtD
Methylphenidate—Dermatitis—Epirubicin—sarcoma	0.000344	0.000344	CcSEcCtD
Methylphenidate—Headache—Epirubicin—sarcoma	0.000342	0.000342	CcSEcCtD
Methylphenidate—Dizziness—Doxorubicin—sarcoma	0.000334	0.000334	CcSEcCtD
Methylphenidate—Nausea—Epirubicin—sarcoma	0.000324	0.000324	CcSEcCtD
Methylphenidate—Vomiting—Doxorubicin—sarcoma	0.000321	0.000321	CcSEcCtD
Methylphenidate—Rash—Doxorubicin—sarcoma	0.000319	0.000319	CcSEcCtD
Methylphenidate—Dermatitis—Doxorubicin—sarcoma	0.000318	0.000318	CcSEcCtD
Methylphenidate—Headache—Doxorubicin—sarcoma	0.000317	0.000317	CcSEcCtD
Methylphenidate—Nausea—Doxorubicin—sarcoma	0.0003	0.0003	CcSEcCtD
